Need Help? Call 1­-866-­796-­7386
« back to stock screener

  NPCE stock: Neuropace Inc

Current Rating
Sell

Previous Rating

Sell
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$7.17
Market Cap
181M
Sector
Health Care
Div. Growth
-
P/E
-
P/B
8.6
P/S
3.33
Dividend %
-
P/CF
83.9
P/FCF
-
Op. Cash Flow
-28.9K
FCF
-1.1
Op. Margin
-65.80%
Net Margin
-77.20%
ROE
-133.70%
ROI
-46.50%
ROA
-38.30%
EPS Growth
3.90%
Current Ratio
8.9
Debt/Equity
152.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
Interpace Biosciences Inc (IDXG) $1.45 - - 4.1M Strong Buy
China SXT Pharmaceuticals Inc (SXTC) $0.59 - - 1.2M Strong Buy
ATI Physical Therapy Inc (ATIP) $6.00 - - 30.8M Strong Buy
CYANOTECH CORP (CYAN) $0.72 - - 4.4M Strong Buy
KORU Medical Systems Inc (KRMD) $2.47 - - 103.6M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More